BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 38567612)

  • 81. New cholinesterase inhibitors for Alzheimer's disease: Structure activity relationship, kinetics and molecular docking studies of 1-butanoyl-3-arylthiourea derivatives.
    Larik FA; Shah MS; Saeed A; Shah HS; Channar PA; Bolte M; Iqbal J
    Int J Biol Macromol; 2018 Sep; 116():144-150. PubMed ID: 29729344
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Novel 6-alkyl-bridged 4-arylalkylpiperazin-1-yl derivatives of azepino[4,3-b]indol-1(2H)-one as potent BChE-selective inhibitors showing protective effects against neurodegenerative insults.
    Samarelli F; Purgatorio R; Lopopolo G; Deruvo C; Catto M; Andresini M; Carrieri A; Nicolotti O; De Palma A; Miniero DV; de Candia M; Altomare CD
    Eur J Med Chem; 2024 Apr; 270():116353. PubMed ID: 38579622
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Design, synthesis, biological activity, molecular docking, and molecular dynamics of novel benzimidazole derivatives as potential AChE/MAO-B dual inhibitors.
    Osmaniye D; Evren AE; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100450. PubMed ID: 34931332
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
    Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
    J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Design and synthesis of novel chalcone derivatives and evaluation of their inhibitory activities against acetylcholinesterase.
    Ceyhun İ; Karaca Ş; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100372. PubMed ID: 34893996
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Design, Synthesis, and Biological Evaluation of a New Series of Biphenyl/Bibenzyl Derivatives Functioning as Dual Inhibitors of Acetylcholinesterase and Butyrylcholinesterase.
    Wang DM; Feng B; Fu H; Liu AL; Wang L; Du GH; Wu S
    Molecules; 2017 Jan; 22(1):. PubMed ID: 28117700
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Avarol derivatives as competitive AChE inhibitors, non hepatotoxic and neuroprotective agents for Alzheimer's disease.
    Tommonaro G; García-Font N; Vitale RM; Pejin B; Iodice C; Cañadas S; Marco-Contelles J; Oset-Gasque MJ
    Eur J Med Chem; 2016 Oct; 122():326-338. PubMed ID: 27376495
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Cholinesterases inhibition and molecular modeling studies of piperidyl-thienyl and 2-pyrazoline derivatives of chalcones.
    Shah MS; Khan SU; Ejaz SA; Afridi S; Rizvi SUF; Najam-Ul-Haq M; Iqbal J
    Biochem Biophys Res Commun; 2017 Jan; 482(4):615-624. PubMed ID: 27865835
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Design, synthesis, and biological evaluation of novel donepezil-tacrine hybrids as multi-functional agents with low neurotoxicity against Alzheimer's disease.
    Wang N; Jia W; Wang J; Yang Z; Liu Y; Huang D; Mei X; Xiong X; Shi J; Tang Y; Chen G; Di D; Hou Y; Liu Y
    Bioorg Chem; 2024 Feb; 143():107010. PubMed ID: 38056387
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Design, synthesis, and biological evaluation of carbamate derivatives of N-salicyloyl tryptamine as multifunctional agents for the treatment of Alzheimer's disease.
    Liu D; Zhang H; Wang Y; Liu W; Yin G; Wang D; Li J; Shi T; Wang Z
    Eur J Med Chem; 2022 Feb; 229():114044. PubMed ID: 34923430
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Design, Synthesis, and Evaluation of Novel 2
    Haji Ali S; Osmaniye D; Sağlık BN; Levent S; Özkay Y; Kaplancıklı ZA
    Molecules; 2022 Mar; 27(7):. PubMed ID: 35408519
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Novel tacrine-1,2,3-triazole hybrids: In vitro, in vivo biological evaluation and docking study of cholinesterase inhibitors.
    Najafi Z; Mahdavi M; Saeedi M; Karimpour-Razkenari E; Asatouri R; Vafadarnejad F; Moghadam FH; Khanavi M; Sharifzadeh M; Akbarzadeh T
    Eur J Med Chem; 2017 Jan; 125():1200-1212. PubMed ID: 27863370
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Design and synthesis of some new carboxamide and propanamide derivatives bearing phenylpyridazine as a core ring and the investigation of their inhibitory potential on in-vitro acetylcholinesterase and butyrylcholinesterase.
    Kilic B; Gulcan HO; Aksakal F; Ercetin T; Oruklu N; Umit Bagriacik E; Dogruer DS
    Bioorg Chem; 2018 Sep; 79():235-249. PubMed ID: 29775949
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Design, synthesis and biological evaluation of benzofuran appended benzothiazepine derivatives as inhibitors of butyrylcholinesterase and antimicrobial agents.
    Mostofi M; Mohammadi Ziarani G; Lashgari N
    Bioorg Med Chem; 2018 Jul; 26(12):3076-3095. PubMed ID: 29866481
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone.
    Hwang J; Youn K; Ji Y; Lee S; Lim G; Lee J; Ho CT; Leem SH; Jun M
    Nutrients; 2020 Apr; 12(5):. PubMed ID: 32344943
    [TBL] [Abstract][Full Text] [Related]  

  • 96. SAR based in-vitro anticholinesterase and molecular docking studies of nitrogenous progesterone derivatives.
    Amin MJ; Miana GA; Rashid U; Rahman KM; Khan HU; Sadiq A
    Steroids; 2020 Jun; 158():108599. PubMed ID: 32126219
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Norditerpenoids with Selective Anti-Cholinesterase Activity from the Roots of
    Ślusarczyk S; Senol Deniz FS; Abel R; Pecio Ł; Pérez-Sánchez H; Cerón-Carrasco JP; den-Haan H; Banerjee P; Preissner R; Krzyżak E; Oleszek W; E Orhan I; Matkowski A
    Int J Mol Sci; 2020 Jun; 21(12):. PubMed ID: 32586060
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Exploring indole-based-thiadiazole derivatives as potent acetylcholinesterase and butyrylcholinesterase enzyme inhibitors.
    Taha M; Rahim F; Uddin N; Khan IU; Iqbal N; Anouar EH; Salahuddin M; Farooq RK; Gollapalli M; Khan KM; Zafar A
    Int J Biol Macromol; 2021 Oct; 188():1025-1036. PubMed ID: 34390751
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Investigation of the toxicological and inhibitory effects of some benzimidazole agents on acetylcholinesterase and butyrylcholinesterase enzymes.
    Türkan F
    Arch Physiol Biochem; 2021 Apr; 127(2):97-101. PubMed ID: 31135232
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Evaluation of Novel Dual Acetyl- and Butyrylcholinesterase Inhibitors as Potential Anti-Alzheimer's Disease Agents Using Pharmacophore, 3D-QSAR, and Molecular Docking Approaches.
    Pang X; Fu H; Yang S; Wang L; Liu AL; Wu S; Du GH
    Molecules; 2017 Jul; 22(8):. PubMed ID: 28933746
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.